7.
Miki C, Kusunoki M, Inoue Y, et al. Remodeling of the immunoinflammatory network system in elderly cancer patients: implications of inflamm-aging and tumor-specific hyperinflammation. Surg Today. 2008;38:873–8.PubMed
8.
Vasto S, Carruba G, Lio D, Colonna-Romano G, Di Bona D, Candore G, Caruso C. Inflammation, ageing and cancer. Mech Ageing Dev. 2009;130:40–5.PubMed
9.
Franceschi C, Capri M, Monti D, Giunta S, Olivieri F, Sevini F, et al. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev. 2007;128:92–105.PubMed
10.
Finn OJ. Immuno-oncology: understanding the function and dysfunction of the immune system in cancer. Ann Oncol. 2012;23 Suppl 8:viii6–9.PubMedCentralPubMed
11.
Dranoff G. Cytokines in cancer pathogenesis and cancer therapy. Nat Rev Cancer. 2004;4:11–22.PubMed
12.
Demaria S, Formenti SC. Role of T lymphocytes in tumor response to radiotherapy. Front Oncol. 2012;2:95.PubMedCentralPubMed
13.
Pawelec G. Hallmarks of human “immunosenescence”: adaptation or dysregulation? Immun Ageing. 2012;9:15.PubMedCentralPubMed
14.
Arnold CR, Wolf J, Brunner S, Herndler-Brandstetter D, Grubeck-Loebenstein B. Gain and loss of T cell subsets in old age – age-related reshaping of the T cell repertoire. J Clin Immunol. 2011;31:137–46.PubMed
15.
Douziech N, Seres I, Larbi A, Szikszay E, Roy PM, Arcand M, Dupuis G, Fulop Jr T. Modulation of human lymphocyte proliferative response with aging. Exp Gerontol. 2002;37:369–87.PubMed
16.
Solana R, Tarazona R, Gayoso I, Lesur O, Dupuis G, Fulop T. Innate immunosenescence: effect of aging on cells and receptors of the innate immune system in humans. Semin Immunol. 2012;24:331–41.PubMed
17.
Desai A, Grolleau-Julius A, Yung R. Leukocyte function in the aging immune system. J Leukoc Biol. 2010;87:1001–9.PubMedCentralPubMed
18.
Fulop T, Larbi A, Kotb R, de Angelis F, Pawelec G. Aging, immunity, and cancer. Discov Med. 2011;11:537–50.PubMed
19.
Fulop T, Kotb R, Fortin CF, Pawelec G, de Angelis F, Larbi A. Potential role of immunosenescence in cancer development. Ann N Y Acad Sci. 2010;1197:158–65.PubMed
20.
Derhovanessian E, Solana R, Larbi A, Pawelec G. Immunity, ageing and cancer. Immun Ageing. 2008;5:11.PubMedCentralPubMed
21.
Mazzola P, Radhi S, Mirandola L, Annoni G, Jenkins M, Cobos E, Chiriva-Internati M. Aging, cancer, and cancer vaccines. Immun Ageing. 2012;9:4.PubMedCentralPubMed
22.
Fulop T, Fortin C, Lesur O, Dupuis G, Kotb R, Lord JM, Larbi A. The innate immune system and aging: what is the contribution to immunosenescence? Open Longev Sci. 2012;6:121–32.
23.
Wessels I, Jansen J, Rink L, Uciechowski P. Immunosenescence of polymorphonuclear neutrophils. Sci World J. 2010;10:145–60.
24.
Fortin CF, McDonald PP, Lesur O, Fülöp Jr T. Aging and neutrophils: there is still much to do. Rejuvenation Res. 2008;11:873–82.PubMed
25.
Fulop Jr T, Foris G, Worum I, Leovey A. Age-dependent alterations of Fc gamma receptor-mediated effector functions of human polymorphonuclear leucocytes. Clin Exp Immunol. 1985;61:425–32.PubMedCentralPubMed
26.
Fulop T, Foris G, Worum I, Leovey A. Age-dependent changes of the Fc gamma-receptor-mediated functions of human monocytes. Int Arch Allergy Appl Immunol. 1984;74:76–9.PubMed
27.
Fulop T, Larbi A, Douziech N, Fortin C, Guérard KP, Lesur O, et al. Signal transduction and functional changes in neutrophils with aging. Aging Cell. 2004;3:217–26.PubMed
28.
Wenisch C, Patruta A, Daxbock F, Krause R, Horl W. Effect of age on human neutrophil functions. J Leukoc Biol. 2000;67:40–5.PubMed
29.
Delgado MA, Elmaoued RA, Davis AS, Kyei G, Deretic V. Toll-like receptors control autophagy. EMBO J. 2008;27:1110–21.PubMedCentralPubMed
30.
Shaw AC, Panda A, Joshi SR, et al. Dysregulation of human Toll-like receptor function in aging. Ageing Res Rev. 2011;10:346–53.PubMedCentralPubMed
31.
Renshaw M, Rockwell J, Engleman C, Gewirtz A, Katz J, Sambhara S. Cutting edge: impaired Toll-like receptor expression and function in aging. J Immunol. 2002;169:4697–701.PubMed
32.
van Duin D, Shaw AC. Toll-like receptors in older adults. J Am Geriatr Soc. 2007;55:1438–44.PubMed
33.
Mankan AK, Dau T, Jenne D, Hornung V. The NLRP3/ASC/Caspase-1 axis regulates IL-1β processing in neutrophils. Eur J Immunol. 2012;42:710–5.PubMed
34.
Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol. 2010;11:373–84.PubMed
35.
Wu S, Metcalf JP, Wu W. Innate immune response to influenza virus. Curr Opin Infect Dis. 2011;24:235–40.PubMed
36.
Kawai T, Akira S. Antiviral signaling through pattern recognition receptors. J Biochem. 2007;141:137–45.PubMed
37.
Casanova JL, Abel L, Quintana-Murci L. Human TLRs and IL-1Rs in host defense: natural insights from evolutionary, epidemiological, and clinical genetics. Annu Rev Immunol. 2011;29:447–91.PubMed
38.
Ostuni R, Zanoni I, Granucci F. Deciphering the complexity of Toll-like receptor signaling. Cell Mol Life Sci. 2010;67:4109–34.PubMed
39.
Kawai T, Akira S. Signaling to NF-kappaB by Toll-like receptors. Trends Mol Med. 2007;13:460–9.PubMed
40.
Puga I, Cols M, Barra CM, He B, Cassis L, et al. B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen. Nat Immunol. 2011;13:170–80.PubMedCentralPubMed
41.
Ryan SO, Johnson JL, Cobb BA. Neutrophils confer T cell resistance to myeloid derived suppressor cells- mediated suppression to promote chronic inflammation. J Immunol. 2013;190:5037–47.PubMedCentralPubMed
42.
Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, Ley K. Development of monocytes, macrophages, and dendritic cells. Science. 2010;327:656–61.PubMedCentralPubMed
43.
Nyugen J, Agrawal S, Gollapudi S, Gupta S. Impaired functions of peripheral blood monocyte subpopulations in aged humans. J Clin Immunol. 2010;30:806–13.PubMedCentralPubMed
44.
Aw D, Silva AB, Palmer DB. Immunosenescence: emerging challenges for an ageing population. Immunology. 2007;120:435–46.PubMedCentralPubMed
45.
Panda A, Arjona A, Sapey E, Bai F, Fikrig E, Montgomery RR, et al. Human innate immunosenescence: causes and consequences for immunity in old age. Trends Immunol. 2009;30:325–33.PubMedCentralPubMed
46.
Crétel E, Veen I, Pierres A, Bongrand P, Gavazzi G. Immunosenescence and infections, myth or reality? Med Mal Infect. 2010;40:307–18.PubMed
47.
Agarwal S, Busse PJ. Innate and adaptive immunosenescence. Ann Allergy Asthma Immunol. 2010;104:183–90.PubMed
48.
Shaw AC, Joshi S, Greenwood H, Panda A, Lord JM. Aging of the innate system. Curr Opin Immunol. 2010;22:507–13.PubMedCentralPubMed
49.
van Duin D, Allore HG, Mohanty S, Ginter S, Newman FK, Belshe RB, et al. Prevaccine determination of the expression of costimulatory B7 molecules in activated monocytes predicts influenza vaccine responses in young and older adults. J Infect Dis. 2007;195:1590–7.PubMed
50.
Plowden J, Renshaw-Hoelscher M, Engleman C, Katz J, Sambhara S. Innate immunity in aging: impact on macrophage function aging. Cell. 2004;3:161–7.
51.
Ashcroft GS, Horan MA, Ferguson MW. Aging alters the inflammatory and endothelial cell adhesion molecule profiles during human cutaneous wound healing. Lab Invest. 1998;78:47–58.PubMed
Related posts:
Role of Innate Immunity in Cancers and Antitumor Response
Prognostic Value of Innate and Adaptive Immunity in Cancers
MHC Class I Molecules and Cancer Progression: Lessons Learned from Preclinical Mouse Models
B Cells in Cancer Immunology: For or Against Cancer Growth?
Cancer Immunoediting: Immunosurveillance, Immune Equilibrium, and Immune Escape
Immunohistochemistry of Cancers
Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree
